Product name:Dabrafenib
CAS: 1195765-45-7
Molecular Formula: C23H20F3N5O2S2
Molecular weight:519.56
Stability:Stable
Shelf life:2 years
Product description :Dabrafenib is a drug for the treatment of cancers associated with a mutated version of the gene BRAF. Dabrafenib acts as an inhibitor of the associated enzyme B-Raf, which plays a role in the regulation of cell growth. Dabrafenib has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma.